Liverpool Drug Interactions Group Interactions with Experimental COVID-19 Therapies
Charts updated 3 April 2020 Page 1 of 5 Please check www.covid19-druginteractions.org for updates. Please note that if a drug is not listed it cannot automatically be assumed it is safe to coadminister. No recommendation to use experimental therapy for COVID-19 is made. Drug interaction data for many agents are limited or absent; therefore, risk-benefit assessment for any individual patient rests with prescribers.
β β
- - ATV LPV/r RDV FAVI CLQ HCLQ RBV TCZ IFN ATV LPV/r RDV FAVI CLQ HCLQ RBV TCZ IFN Anaesthetics & Muscle Relaxants Antibacterials Alcuronium Amikacin Bupivacaine Amoxicillin Cisatracurium Ampicillin Desflurane Azithromycin Dexmedetomidine Bedaquiline Enflurane Capreomycin Ephedrine Cefalexin Etidocaine Cefazolin Halothane Cefixime Isoflurane Cefotaxime Ketamine Ceftazidime Minaxolone Ceftriaxone Nitrous oxide Chloramphenicol Propofol Ciprofloxacin Rocuronium Clarithromycin Sevoflurane Clavulanic acid Sufentanil Clindamycin Suxamethonium (succinylcholine) Clofazimine Tetracaine Cloxacillin Thiopental Cycloserine Tizanidine Dapsone Vecuronium Delamanid Analgesics Doxycycline Alfentanil Ertapenem Aspirin Erythromycin Buprenorphine Ethambutol Celecoxib Ethionamide Codeine Flucloxacillin Dextropropoxyphene Diamorphine (diacetylmorphine) Gentamicin Diclofenac Imipenem/Cilastatin Dihydrocodeine Isoniazid Fentanyl Kanamycin Hydrocodone Levofloxacin Hydromorphone Linezolid Ibuprofen Meropenem Mefenamic acid Metronidazole Metamizole Moxifloxacin Methadone Nitrofurantoin Morphine Ofloxacin Naproxen Para-aminosalicylic acid Nimesulide Penicillins Oxycodone Piperacillin Paracetamol (Acetaminophen) Pyrazinamide Pethidine (Meperidine) Rifabutin Piroxicam Rifampicin Remifentanil Rifapentine Tapentadol Rifaximin Tramadol Spectinomycin Antiarrhythmics Streptomycin Amiodarone Sulfadiazine Bepridil Tazobactam Disopyramide Telithromycin Dofetilide Tetracyclines Flecainide Tinidazole Lidocaine (Lignocaine) Trimethoprim/Sulfamethoxazole Mexiletine Vancomycin Propafenone Quinidine
Key to abbreviations Key to symbols ATV Atazanavir CLQ Chloroquine These drugs should not be coadministered LPV/r Lopinavir/ritonavir HCLQ Hydroxychloroquine Potential interaction - may require close monitoring, alteration of drug dosage or timing of administration RDV Remdesivir RBV Ribavirin Potential interaction likely to be of weak intensity. FAVI Favipiravir TCZ Tocilizumab Additional action/monitoring or dosage adjustment is unlikely to be required IFN-β Interferon beta No clinically significant interaction expected
© Liverpool Drug Interaction Group, University of Liverpool, Pharmacology Research Labs, 1st Floor Block H, 70 Pembroke Place, LIVERPOOL, L69 3GF We aim to ensure that information is accurate and consistent with current knowledge and practice. However, the University of Liverpool and its servants or agents shall not be responsible or in any way liable for the continued currency of information in this publication whether arising from negligence or otherwise howsoever or for any consequences arising therefrom. The University of Liverpool expressly exclude liability for errors, omissions or inaccuracies to the fullest extent permitted by law. Liverpool Drug Interactions Group Interactions with Experimental COVID-19 Therapies
Charts updated 3 April 2020 Page 2 of 5 Please check www.covid19-druginteractions.org for updates. Please note that if a drug is not listed it cannot automatically be assumed it is safe to coadminister. No recommendation to use experimental therapy for COVID-19 is made. Drug interaction data for many agents are limited or absent; therefore, risk-benefit assessment for any individual patient rests with prescribers.
β β
- - ATV LPV/r RDV FAVI CLQ HCLQ RBV TCZ IFN ATV LPV/r RDV FAVI CLQ HCLQ RBV TCZ IFN Anti-coagulant, Anti-platelet and Fibrinolytic Antidepressants Acenocoumarol Agomelatine Apixaban Amitriptyline Argatroban Bupropion Aspirin (anti-platelet) Citalopram Betrixaban Clomipramine Clopidogrel Desipramine Dabigatran Doxepin Dalteparin Duloxetine Dipyridamole Escitalopram Edoxaban Fluoxetine Eltrombopag Fluvoxamine Enoxaparin Imipramine Fondaparinux Lithium Heparin Maprotiline Phenprocoumon Mianserin Prasugrel Milnacipran Rivaroxaban Mirtazapine Streptokinase Nefazodone Ticagrelor Nortriptyline Warfarin Paroxetine Anticonvulsants Phenelzine Carbamazepine Reboxetine Clonazepam Sertraline Eslicarbazepine St John’s wort Ethosuximide Tranylcypromine Gabapentin Trazodone Lacosamide Trimipramine Lamotrigine Venlafaxine Levetiracetam Vortioxetine Oxcarbazepine Anti-diabetics Perampanel Acarbose Phenobarbital (Phenobarbitone) Canagliflozin Phenytoin Dapagliflozin Pregabalin Dulaglutide Primidone Empagliflozin Retigabine Exanatide Rufinamide Glibenclamide (Glyburide) Sultiame Gliclazide Tiagabine Glimepiride Topiramate Glipizide Valproate (Divalproex) Insulin Vigabatrin Linagliptin Zonisamide Liraglutide Metformin Nateglinide Pioglitazone Repaglinide Rosiglitazone Saxagliptin Sitagliptin Tolbutamide Vildagliptin
Key to abbreviations Key to symbols ATV Atazanavir CLQ Chloroquine These drugs should not be coadministered LPV/r Lopinavir/ritonavir HCLQ Hydroxychloroquine Potential interaction - may require close monitoring, alteration of drug dosage or timing of administration RDV Remdesivir RBV Ribavirin Potential interaction likely to be of weak intensity. FAVI Favipiravir TCZ Tocilizumab Additional action/monitoring or dosage adjustment is unlikely to be required IFN-β Interferon beta No clinically significant interaction expected
© Liverpool Drug Interaction Group, University of Liverpool, Pharmacology Research Labs, 1st Floor Block H, 70 Pembroke Place, LIVERPOOL, L69 3GF We aim to ensure that information is accurate and consistent with current knowledge and practice. However, the University of Liverpool and its servants or agents shall not be responsible or in any way liable for the continued currency of information in this publication whether arising from negligence or otherwise howsoever or for any consequences arising therefrom. The University of Liverpool expressly exclude liability for errors, omissions or inaccuracies to the fullest extent permitted by law. Liverpool Drug Interactions Group Interactions with Experimental COVID-19 Therapies
Charts updated 3 April 2020 Page 3 of 5 Please check www.covid19-druginteractions.org for updates. Please note that if a drug is not listed it cannot automatically be assumed it is safe to coadminister. No recommendation to use experimental therapy for COVID-19 is made. Drug interaction data for many agents are limited or absent; therefore, risk-benefit assessment for any individual patient rests with prescribers.
β β
- - ATV LPV/r RDV FAVI CLQ HCLQ RBV TCZ IFN ATV LPV/r RDV FAVI CLQ HCLQ RBV TCZ IFN Antifungals Antivirals - Covid Amphotericin B Atazanavir Anidulafungin Lopinavir/ritonavir Caspofungin Remdesivir Fluconazole Favipiravir Flucytosine Chloroquine Griseofulvin Hydroxychloroquine Isavuconazole Ribavirin Itraconazole Tocilizumab Ketoconazole Interferon beta Micafungin Antivirals - HCV DAAs Miconazole Elbasvir/Grazoprevir Nystatin Glecaprevir/Pibrentasvir Posaconazole Ledipasvir/Sofosbuvir Terbinafine Ombitasvir/Paritaprevir/r Voriconazole Ombitasvir/Paritaprevir/r + Dasabuvir Antipsychotics/Neuroleptics Sofosbuvir Amisulpride Sofosbuvir/Velpatasvir Aripiprazole Sofosbuvir/Velpatasvir/Voxilaprevir Asenapine Antivirals - others Chlorpromazine Oseltamivir Clozapine Anxiolytics/Hypnotics/Sedatives Fluphenazine Alprazolam Haloperidol Bromazepam Iloperidone Buspirone Levomepromazine Chlordiazepoxide Olanzapine Clobazam Paliperidone Clorazepate Perazine Diazepam Periciazine Estazolam Perphenazine Flunitrazepam Pimozide Flurazepam Pipotiazine Hydroxyzine Quetiapine Lorazepam Risperidone Lormetazepam Sulpiride Midazolam (oral) Thioridazine Midazolam (parenteral) Tiapride Oxazepam Ziprasidone Temazepam Zotepine Triazolam Zuclopenthixol Zaleplon Zolpidem Zopiclone
ATV and LPV/r are not intended to be combined for the treatment of COVID-19
Key to abbreviations Key to symbols ATV Atazanavir CLQ Chloroquine These drugs should not be coadministered LPV/r Lopinavir/ritonavir HCLQ Hydroxychloroquine Potential interaction - may require close monitoring, alteration of drug dosage or timing of administration RDV Remdesivir RBV Ribavirin Potential interaction likely to be of weak intensity. FAVI Favipiravir TCZ Tocilizumab Additional action/monitoring or dosage adjustment is unlikely to be required IFN-β Interferon beta No clinically significant interaction expected
© Liverpool Drug Interaction Group, University of Liverpool, Pharmacology Research Labs, 1st Floor Block H, 70 Pembroke Place, LIVERPOOL, L69 3GF We aim to ensure that information is accurate and consistent with current knowledge and practice. However, the University of Liverpool and its servants or agents shall not be responsible or in any way liable for the continued currency of information in this publication whether arising from negligence or otherwise howsoever or for any consequences arising therefrom. The University of Liverpool expressly exclude liability for errors, omissions or inaccuracies to the fullest extent permitted by law. Liverpool Drug Interactions Group Interactions with Experimental COVID-19 Therapies
Charts updated 3 April 2020 Page 4 of 5 Please check www.covid19-druginteractions.org for updates. Please note that if a drug is not listed it cannot automatically be assumed it is safe to coadminister. No recommendation to use experimental therapy for COVID-19 is made. Drug interaction data for many agents are limited or absent; therefore, risk-benefit assessment for any individual patient rests with prescribers.
β β
- - ATV LPV/r RDV FAVI CLQ HCLQ RBV TCZ IFN ATV LPV/r RDV FAVI CLQ HCLQ RBV TCZ IFN Beta Blockers Contraceptives/HRT Atenolol Desogestrel (COC) Bisoprolol Desogestrel (POP) Carvedilol Drospirenone (COC) Metoprolol Drospirenone (HRT) Nebivolol Dydrogesterone (HRT) Oxprenolol Estradiol Pindolol Ethinylestradiol Propranolol Etonogestrel (implant) Timolol Etonogestrel (vaginal ring) Bronchodilators Gestodene (COC) Aclidinium bromide Levonorgestrel (COC) Aminophylline Levonorgestrel (emergency contrac.) Formoterol Levonorgestrel (HRT) Glycopyrronium bromide Levonorgestrel (implant) Indacaterol Levonorgestrel (IUD) Ipratropium bromide Levonorgestrel (POP) Montelukast Medroxyprogesterone (depot inj.) Olodaterol Medroxyprogesterone (oral) Roflumilast Norelgestromin (patch) Salbutamol Norethisterone (COC) Salmeterol Norethisterone (HRT) Theophylline Norethisterone (IM depot) Tiotropium bromide Norethisterone(POP) Umeclidinium bromide Norgestimate (COC) Vilanterol Norgestrel (COC) Calcium Channel Blockers Norgestrel (HRT) Amlodipine Ulipristal Diltiazem Gastrointestinal Agents Felodipine Alosetron Nicardipine Antacids Nifedipine Bisacodyl Nisoldipine Cimetidine Nitrendipine Cisapride Verapamil Esomeprazole Famotidine Lactulose Lansoprazole Loperamide Mesalazine Omeprazole Pantoprazole Prucalopride Rabeprazole Ranitidine Senna Gastrointestinal Agents (anti-emetics) Aprepitant Dolasetron Domperidone Dronabinol Granisetron Metoclopramide Ondansetron Prochlorperazine
Key to abbreviations Key to symbols ATV Atazanavir CLQ Chloroquine These drugs should not be coadministered LPV/r Lopinavir/ritonavir HCLQ Hydroxychloroquine Potential interaction - may require close monitoring, alteration of drug dosage or timing of administration RDV Remdesivir RBV Ribavirin Potential interaction likely to be of weak intensity. FAVI Favipiravir TCZ Tocilizumab Additional action/monitoring or dosage adjustment is unlikely to be required IFN-β Interferon beta No clinically significant interaction expected
© Liverpool Drug Interaction Group, University of Liverpool, Pharmacology Research Labs, 1st Floor Block H, 70 Pembroke Place, LIVERPOOL, L69 3GF We aim to ensure that information is accurate and consistent with current knowledge and practice. However, the University of Liverpool and its servants or agents shall not be responsible or in any way liable for the continued currency of information in this publication whether arising from negligence or otherwise howsoever or for any consequences arising therefrom. The University of Liverpool expressly exclude liability for errors, omissions or inaccuracies to the fullest extent permitted by law. Liverpool Drug Interactions Group Interactions with Experimental COVID-19 Therapies
Charts updated 3 April 2020 Page 5 of 5 Please check www.covid19-druginteractions.org for updates. Please note that if a drug is not listed it cannot automatically be assumed it is safe to coadminister. No recommendation to use experimental therapy for COVID-19 is made. Drug interaction data for many agents are limited or absent; therefore, risk-benefit assessment for any individual patient rests with prescribers.
β β
- - ATV LPV/r RDV FAVI CLQ HCLQ RBV TCZ IFN ATV LPV/r RDV FAVI CLQ HCLQ RBV IFN TCZ Hypertension / Heart Failure Agents Immunosuppressants Aliskiren Adalimumab Ambrisentan Anti-thymocyte globulin Amiloride Azathioprine Benazepril Basiliximab Bendroflumethiazide Belatacept Bosentan Ciclosporin Candesartan Mycophenolate Captopril Pirfenidone Chlortalidone Sirolimus Cilazapril Tacrolimus Clonidine Inotropes & Vasopressors Digoxin Adrenaline (Epinephrine) Dopamine Dobutamine Doxazosin Noradrenaline Enalapril Vasopressin Eplerenone Lipid Lowering Agents Epoprostenol Atorvastatin Eprosartan Bezafibrate Fosinopril Clofibrate Furosemide Evolocumab Hydralazine Ezetimibe Hydrochlorothiazide Fenofibrate Iloprost Fish oils Indapamide Fluvastatin Irbesartan Gemfibrozil Isosorbide dinitrate Lovastatin Ivabradine Pitavastatin Labetalol Pravastatin Lacidipine Rosuvastatin Lercanidipine Simvastatin Lisinopril Steroids Losartan Beclometasone Macitentan Betamethasone Methyldopa Budesonide Metolazone Ciclesonide Moxonidine Clobetasol Olmesartan Dexamethasone Perindopril Fludrocortisone Prazosin Flunisolide Quinapril Fluocinolone Ramipril Fluticasone Ranolazine Hydrocortisone (oral) Riociguat Hydrocortisone (topical) Sacubitril Megestrol acetate Selexipag Methylprednisolone Sildenafil (PAH) Mometasone Sodium nitroprusside Nandrolone Spironolactone Oxandrolone Tadalafil (PAH) Prednisolone Telmisartan Prednisone Terazosin Stanazolol Torasemide Testosterone Trandolapril Triamcinolone Treprostinil Valsartan Xipamide
Key to abbreviations Key to symbols ATV Atazanavir CLQ Chloroquine These drugs should not be coadministered LPV/r Lopinavir/ritonavir HCLQ Hydroxychloroquine Potential interaction - may require close monitoring, alteration of drug dosage or timing of administration RDV Remdesivir RBV Ribavirin Potential interaction likely to be of weak intensity. FAVI Favipiravir TCZ Tocilizumab Additional action/monitoring or dosage adjustment is unlikely to be required IFN-β Interferon beta No clinically significant interaction expected
© Liverpool Drug Interaction Group, University of Liverpool, Pharmacology Research Labs, 1st Floor Block H, 70 Pembroke Place, LIVERPOOL, L69 3GF We aim to ensure that information is accurate and consistent with current knowledge and practice. However, the University of Liverpool and its servants or agents shall not be responsible or in any way liable for the continued currency of information in this publication whether arising from negligence or otherwise howsoever or for any consequences arising therefrom. The University of Liverpool expressly exclude liability for errors, omissions or inaccuracies to the fullest extent permitted by law.